Deutsche Bank
MBII

Deutsche Bank’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Deutsche Bank’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-55,724
Closed -$61K – 4441
2022
Q1 		$61K Sell
55,724
-6,533
-10% -$4.93K ﹤0.01% 3770
2021
Q4 		$45K Buy
62,257
+3,206
+5% +$2.59K ﹤0.01% 3987
2021
Q3 		$53K Sell
59,051
-128,759
-69% -$155K ﹤0.01% 4106
2021
Q2 		$312K Buy
187,810
+15,911
+9% +$26.6K ﹤0.01% 3523
2021
Q1 		$359K Sell
171,899
-4,081
-2% -$8.48K ﹤0.01% 3310
2020
Q4 		$220K Buy
175,980
+13,558
+8% +$16.2K ﹤0.01% 3416
2020
Q3 		$198K Buy
162,422
+3,258
+2% +$3.96K ﹤0.01% 3224
2020
Q2 		$186K Buy
159,164
+141,833
+818% +$131K ﹤0.01% 3174
2020
Q1 		$14K Sell
17,331
-1,054
-6% -$1.12K ﹤0.01% 3995
2019
Q4 		$18K Buy
18,385
+3,555
+24% +$4.31K ﹤0.01% 4339
2019
Q3 		$19K Sell
14,830
-28,563
-66% -$40.3K ﹤0.01% 4351
2019
Q2 		$63K Sell
43,393
-25,107
-37% -$38.8K ﹤0.01% 4422
2019
Q1 		$103K Sell
68,500
-2,802
-4% -$4.28K ﹤0.01% 4295
2018
Q4 		$103K Sell
71,302
-52,361
-42% -$80.2K ﹤0.01% 4213
2018
Q3 		$227K Buy
123,663
+19,056
+18% +$37K ﹤0.01% 4182
2018
Q2 		$192K Buy
+104,607
New +$195K ﹤0.01% 4304
2016
Q2 		– Sell
-456
Closed – – 5411
2016
Q1 		$0 Sell
456
-2,544
-85% -$2.56K ﹤0.01% 5404
2015
Q4 		$3K Buy
3,000
+2,000
+200% +$4.28K ﹤0.01% 5120
2015
Q3 		$2K Sell
1,000
-54,804
-98% -$107K ﹤0.01% 5118
2015
Q2 		$110K Sell
55,804
-14,900
-21% -$42.2K ﹤0.01% 4194
2015
Q1 		$272K Sell
70,704
-22,414
-24% -$83K ﹤0.01% 3631
2014
Q4 		$334K Sell
93,118
-29,013
-24% -$76.8K ﹤0.01% 3975
2014
Q3 		$324K Buy
122,131
+42,524
+53% +$284K ﹤0.01% 3775
2014
Q2 		$924K Buy
79,607
+15,498
+24% +$176K ﹤0.01% 3006
2014
Q1 		$895K Buy
64,109
+8,436
+15% +$133K ﹤0.01% 2941
2013
Q4 		$988K Buy
55,673
+25,034
+82% +$407K ﹤0.01% 2663
2013
Q3 		$516K Buy
+30,639
New +$430K ﹤0.01% 3466

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Deutsche Bank's MBII Position: Q2 2022 in Review

Deutsche Bank sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 55,724 shares — an estimated $61K sold.

Deutsche Bank first reported a position in MBII in Q3 2013 and held it in 27 quarters. The position peaked at $988K in Q4 2013. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Deutsche Bank reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 55,724 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $61K.
  • Deutsche Bank first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 27 quarters.
  • Deutsche Bank's Marrone Bio Innovations, Inc. position peaked at $988K in Q4 2013.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.